Easy come, easy go.
Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion --NYTimes 8/5/09
Not really.
Caught between a pivotal industry ally and the protests of Congressional Democrats, the Obama administration on Friday backed away from what drug industry lobbyists had said this week was a firm White House promise to exclude from a proposed health care overhaul the possibility of allowing the government to negotiate lower drug prices under Medicare. --NYTimes 8/7/09
The drug industry is willing to spend $150 million supporting "reform." How's that working out for you boyzzz?
HT: AmSpecBlog
No comments:
Post a Comment